Newsbenzinga
Full Transcript: Nektar Therapeutics Q2 2026 Earnings Call
· Published
Article summary
Nektar Therapeutics (NASDAQ:NKTR) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data
An excerpt from the original article.
Comments —
Loading comments…